Fund raise · Wednesday 7 October 2026
TCG Crossover (TCGX) closes $600m Asia life sciences fund
TCG Crossover (TCGX) closed TCGX Asia Life Sciences Fund I at $600 million, targeting biotechnology companies based in Asia.
Manager
TCG Crossover (TCGX)
Fund
TCGX Asia Life Sciences Fund I
Amount
$600m
Stage
Final close
Announced
Wednesday 7 October 2026
More fundraising news · past 20 days
Town Lane closes second real estate opportunities fund at $1.9bn
Monday 26 October · $1.9bn · Final close
RCG Ventures closes eighth fund at $515m
Monday 26 October · $515m · Final close
GEM closes $685m independent sponsor fund
Thursday 22 October · $685m · Final close
€600m first close for Seaya's growth vehicle
Thursday 22 October · €600m · First close
$1bn fund triples predecessor at Northwind Group
Wednesday 21 October · $1bn · Final close
Ascertis Credit reaches $700m toward target
Wednesday 21 October · $700m · Final close
$589m close for Monomoy's lower-middle-market fund
Tuesday 20 October · $589m · Final close
$450m closes for Inspired Capital's fourth fund
Tuesday 20 October · $450m · Final close
Blackstone closes $8.7bn energy transition fund
Monday 19 October · $8.7bn · Final close
$3.5bn vehicle backs Permian minerals at EnCap
Monday 19 October · $3.5bn · Final close
The Fundraising Monitor is a proprietary automated review. It records the fund raises AIP has tracked, not a complete count of the market, and nothing in it is investment advice or a recommendation.
Receive The Alternative Investor each month, with news and features from across private capital.
Subscribe